Related Experiment Video
Updated: Oct 4, 2025

07:13
Application of Ultrasound and Shear Wave Elastography Imaging in a Rat Model of NAFLD/NASH
Published on: April 20, 2021
4.2K
Shear wave elastography and shear wave dispersion imaging in primary biliary cholangitis-a pilot study
Marten Schulz1, Anne-Christin B Wilde1, Münevver Demir1
1Department of Hepatology and Gastroenterology, Charité - Universitätsmedizin Berlin, Campus Virchow-Klinikum (CVK) and Campus Charité Mitte (CCM), Berlin, Germany.
Quantitative Imaging in Medicine and Surgery
|February 3, 2022
Summary
Two-dimensional shear wave elastography (2D-SWE) reliably assesses liver fibrosis in primary biliary cholangitis (PBC). New methods like shear wave dispersion imaging (SWD) show potential for evaluating disease activity by correlating with prognostic markers.
Area of Science:
- Hepatology
- Medical Imaging
- Non-invasive Diagnostics
Background:
- Primary biliary cholangitis (PBC) is a chronic liver disease.
- Fibrosis and cirrhosis are common complications of PBC.
- Two-dimensional shear wave elastography (2D-SWE) is an emerging technique for fibrosis assessment, but data in PBC is limited.
Purpose of the Study:
- To evaluate the effectiveness of 2D-SWE for characterizing liver disease severity in PBC patients.
- To explore the utility of novel non-invasive imaging methods, attenuation imaging (ATI) and shear wave dispersion imaging (SWD), in PBC.
Main Methods:
- Twenty-two PBC patients underwent 2D-SWE, SWD, and ATI.
- Established non-invasive fibrosis and steatosis assessment methods were used.
- Liver function tests were performed concurrently.
Main Results:
- 2D-SWE showed significant correlations with spleen length, platelet count, non-invasive fibrosis scores (FIB-4, APRI), and transient elastography (TE).
- Shear wave dispersion imaging (SWD) correlated with alkaline phosphatase (ALP) levels, a known prognostic marker in PBC.
Conclusions:
- 2D-SWE is a reliable non-invasive method for assessing liver fibrosis in PBC.
- SWD shows promise as a valuable tool for evaluating liver disease activity in PBC, particularly due to its correlation with ALP.

